loadpatents
name:-0.026541948318481
name:-0.014462947845459
name:-0.011414051055908
DAMSCHRODER; Melissa Patent Filings

DAMSCHRODER; Melissa

Patent Applications and Registrations

Patent applications and USPTO patent grants for DAMSCHRODER; Melissa.The latest application filed is for "combination therapies using anti-pseudomonas psl and pcrv binding molecules".

Company Profile
12.21.42
  • DAMSCHRODER; Melissa - Gaithersburg MD
  • Damschroder; Melissa - Germantown MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules
App 20220177554 - DIGIANDOMENICO; Antonio ;   et al.
2022-06-09
Combinations Of Anti-staphylococcus Aureus Antibodies
App 20220089699 - TKACZYK; Christine ;   et al.
2022-03-24
Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv
Grant 11,203,633 - Digiandomenico , et al. December 21, 2
2021-12-21
Antibodies Directed Against Staphylococcus Aureus Leukotoxins
App 20210363229 - TKACZYK; Christine ;   et al.
2021-11-25
Combinations of anti-Staphylococcus aureus antibodies
Grant 11,168,133 - Tkaczyk , et al. November 9, 2
2021-11-09
Antibodies directed against Staphylococcus aureus leukotoxins
Grant 11,059,884 - Tkaczyk , et al. July 13, 2
2021-07-13
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease
App 20210061906 - Damschroder; Melissa ;   et al.
2021-03-04
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules
App 20200317757 - DIGIANDOMENICO; Antonio ;   et al.
2020-10-08
Binding Molecules Specific For Il-21 And Uses Thereof
App 20200164069 - Ettinger; Catherine ;   et al.
2020-05-28
Combinations Of Anti-staphylococcus Aureus Antibodies
App 20200109189 - TKACZYK; Christine ;   et al.
2020-04-09
Antibodies Directed Against Staphylococcus Aureus Leukotoxins
App 20200109190 - TKACZYK; Christine ;   et al.
2020-04-09
Combination therapies using anti-pseudomonas PSL and PCRV binding molecules
Grant 10,597,439 - Digiandomenico , et al.
2020-03-24
Antibodies specific for IL-21 and uses thereof
Grant 10,588,969 - Ettinger , et al.
2020-03-17
Binding Molecules Specific For Cd73 And Uses Thereof
App 20200079877 - HAY; Carl ;   et al.
2020-03-12
Binding molecules specific for CD73 and uses thereof
Grant 10,556,968 - Hay , et al. Feb
2020-02-11
Binding Molecules Specific For Cd73 And Uses Thereof
App 20190292274 - HAY; Carl ;   et al.
2019-09-26
Humanized Anti-OX40 Antibodies and Uses Thereof
App 20190169303 - Hammond; Scott A. ;   et al.
2019-06-06
Binding molecules specific for CD73 and uses thereof
Grant 10,287,362 - Hay , et al.
2019-05-14
Bispecific HER2 antibodies
Grant 10,160,812 - Li , et al. Dec
2018-12-25
Method of treating cancer with humanized anti-OX40 antibodies
Grant 10,150,815 - Hammond , et al. Dec
2018-12-11
Binding Molecules Specific For Il-21 And Uses Thereof
App 20180318416 - Ettinger; Catherine ;   et al.
2018-11-08
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease
App 20180273621 - Damschroder; Melissa ;   et al.
2018-09-27
Antibodies specific for IL-21 and uses thereof
Grant 10,022,443 - Ettinger , et al. July 17, 2
2018-07-17
Binding Molecules Specific For Cd73 And Uses Thereof
App 20180194858 - HAY; Carl ;   et al.
2018-07-12
Binding molecules specific for CD73 and uses thereof
Grant 9,938,356 - Hay , et al. April 10, 2
2018-04-10
Humanized Anti-ox40 Antibodies And Uses Thereof
App 20180072808 - HAMMOND; SCOTT A. ;   et al.
2018-03-15
Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
Grant 9,896,505 - Damschroder , et al. February 20, 2
2018-02-20
Bispecific Her2 Antibodies
App 20170291955 - Li; John ;   et al.
2017-10-12
Humanized anti-OX40 antibodies and uses thereof
Grant 9,738,723 - Hammond , et al. August 22, 2
2017-08-22
OX40L fusion proteins and uses thereof
Grant 9,718,870 - Damschroder , et al. August 1, 2
2017-08-01
Multi-specific Anti-pseudomonas Psl And Pcrv Binding Molecules And Uses Thereof
App 20170183397 - DIGIANDOMENICO; Antonio ;   et al.
2017-06-29
Binding Molecules Specific For Il-21 And Uses Thereof
App 20170173149 - Ettinger; Catherine ;   et al.
2017-06-22
Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of use
Grant 9,527,905 - Sellman , et al. December 27, 2
2016-12-27
Binding Molecules Specific For Cd73 And Uses Thereof
App 20160194407 - HAY; Carl ;   et al.
2016-07-07
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease
App 20160145335 - Damschroder; Melissa ;   et al.
2016-05-26
Humanized Anti-ox40 Antibodies And Uses Thereof
App 20160137740 - HAMMOND; SCOTT A. ;   et al.
2016-05-19
Ox40l Fusion Proteins And Uses Thereof
App 20160024176 - Damschroder; Melissa ;   et al.
2016-01-28
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules
App 20150284450 - Digiandomenico; Antonio ;   et al.
2015-10-08
Combination Therapies Using Anti-pseudomonas Psl And Pcrv Binding Molecules
App 20150023966 - Digiandomenico; Antonio ;   et al.
2015-01-22
Humanized anti-CD19 antibodies
Grant 8,883,992 - Damschroder , et al. November 11, 2
2014-11-11
Modulation Of Antibody Effector Function By Hinge Domain Engineering
App 20140171623 - Dall'Acqua; William ;   et al.
2014-06-19
Modulation of antibody effector function by hinge domain engineering
Grant 8,697,396 - Dall'Acqua , et al. April 15, 2
2014-04-15
Antibodies That Specifically Bind Staphylococcus Aureus Alpha Toxin And Methods Of Use
App 20140072577 - Sellman; Bret ;   et al.
2014-03-13
Humanized Anti-cd19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease
App 20130115657 - Damschroder; Melissa ;   et al.
2013-05-09
Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
Grant 8,323,653 - Damschroder , et al. December 4, 2
2012-12-04
Modulation Of Antibody Effector Function By Hinge Domain Engineering
App 20120046450 - Dall'Acqua; William ;   et al.
2012-02-23
Modulation of antibody effector function by hinge domain engineering
Grant 8,008,443 - Dall'Acqua , et al. August 30, 2
2011-08-30
Hinge Domain Engineering
App 20110077383 - Dall'Acqua; William ;   et al.
2011-03-31
Framework-Shuffling Of Antibodies
App 20100216975 - WU; Herren ;   et al.
2010-08-26
Increasing The Production Of Recombinant Antibodies In Mammalian Cells By Site-Directed Mutagenesis
App 20100145028 - DALL'ACQUA; William ;   et al.
2010-06-10
Humanization Of Antibodies
App 20090297514 - WU; Herren ;   et al.
2009-12-03
Affinity Optimized Epha2 Agonistic Antibodies And Methods Of Use Thereof
App 20090220527 - Damschroder; Melissa ;   et al.
2009-09-03
Modulation Of Antibody Effector Function By Hinge Domain Engineering
App 20090221803 - Dall'Acqua; William ;   et al.
2009-09-03
Humanized Anti-CD19 Antibodies And Their Use In Treatment Of Oncology, Transplantation And Autoimmune Disease
App 20080138336 - Damschroder; Melissa ;   et al.
2008-06-12
Framework-shuffling of antibodies
App 20060228350 - Wu; Herren ;   et al.
2006-10-12
Modulation of antibody specificity by tailoring the affinity to cognate antigens
App 20060121042 - Dall'Acqua; William ;   et al.
2006-06-08
Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis
App 20060019342 - Dall'Acqua; William ;   et al.
2006-01-26
Periplasmic expression of antibodies using a single signal sequence
App 20050181479 - Dall'Acqua, William ;   et al.
2005-08-18
Humanization of antibodies
App 20050048617 - Wu, Herren ;   et al.
2005-03-03
Humanization of antibodies
App 20050042664 - Wu, Herren ;   et al.
2005-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed